Safety concerns of aztreonam: a real-world disproportionality analysis based on FDA Adverse Event Reporting System
Year: 2024
Type: article
Source: Expert Opinion on Drug Safety
Institution: Fujian Medical University
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4404568206
